Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir in pediatric kidney transplant recipients
NCT01376804Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Roche. Started Jul 2011; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01376804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376804.